TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.

Thomas M File et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.